Tsp Capital Management Group, LLC Celldex Therapeutics, Inc. Transaction History
Tsp Capital Management Group, LLC
- $270 Million
- Q1 2024
A detailed history of Tsp Capital Management Group, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Tsp Capital Management Group, LLC holds 249,220 shares of CLDX stock, worth $9.06 Million. This represents 3.88% of its overall portfolio holdings.
Number of Shares
249,220
Previous 251,495
0.9%
Holding current value
$9.06 Million
Previous $9.97 Million
4.86%
% of portfolio
3.88%
Previous 3.91%
Shares
21 transactions
Others Institutions Holding CLDX
# of Institutions
206Shares Held
61.2MCall Options Held
291KPut Options Held
246K-
Wellington Management Group LLP Boston, MA7.65MShares$278 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.51MShares$164 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.65MShares$133 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.12MShares$113 Million2.11% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$112 Million0.02% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.7B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...